Maternal Supplementation of Inositols, Fucoxanthin, and Hydroxytyrosol in Pregnant Murine Models of Hypertension. (17th March 2020)

• Record Type: Journal Article
• Authors: Menichini, Daniela; Alrais, Mesk; Liu, Chen; Xia, Yang; Blackwell, Sean C; Facchinetti, Fabio; Sibai, Baha M; Longo, Monica
• Is Part Of: American journal of hypertension. Volume 33:Number 7(2020)
• Page Start: 652
• Page End: 659
• Publication Date: 2020-03-17
• Subjects: blood pressure -- endothelial nitric oxide synthase -- fucoxanthin -- high fat diet -- hydroxytyrosol -- hypertension -- inositol -- obesity -- pregnancy; Hypertension -- Periodicals; 616.132005
• DOI: 10.1093/ajh/hpaa041
• Languages: English
• ISSNs: 0895-7061

Abstract

Abstract: Background: Myoinositol (M) and D-chiro-inositol (D) are insulin sensitizer compounds, while fucoxanthin (F) and hydroxytyrosol (H) are antioxidant substances. We aim to investigate if the combination of these compounds, will improve the vascular responses in pregnant mouse models of hypertension: a genetic model, transgenic heterozygous mice lacking endothelial nitric oxide synthase gene (eNOS −/+ ); and environmental, wild-type (WT) mice. Those mouse models will allow a better understanding of the genetic/environmental contribution to hypertension in pregnancy. Methods: eNOS −/+ and WT female were fed high fat diet for 4 weeks, then at 7–8 weeks of age were mated with WT male. On gestational day (GD) 1, they were randomly allocated to receive MDFH treatment or water as control: eNOS −/+ MDFH ( n = 13), eNOS −/+ ( n = 13), WT-MDFH ( n = 14), and WT ( n = 20). Systolic blood pressure (SBP) was obtained at GD 18, then dams were sacrificed; fetuses and placentas collected, and 2 mm segments of carotid arteries isolated for vascular responses using the wire-myograph system. Responses to phenylephrine (PE), with/without the NOS inhibitor ( N -nitro-l -arginine methyl ester (l -NAME)), and to acetylcholine (Ach) and sodium nitroprussiate (SNP) were performed. Results: SBP decreased in eNOS −/+ and WT dams after MDFH supplementation. In eNOS −/+, MDFH lower the contractile response to PE and l -NAME and improved Ach vasorelaxation. In WT dams, MDFH treatment did not affect PE response; MDFH treatment lowered the vascular PE response after incubation with l -NAME. No differences were seen in SNP relaxation in both models. Conclusions: MDFH decreased SBP in both genetically and environmentally hypertensive dams and improved vascular responses mostly in the eNOS −/+ dams. Graphical Abstract: